Forte Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $6 | $6 | $0 |
Gross Profit | -10 | -9 | -6 | -3 |
EBITDA | -12,808 | -7,795 | -6,375 | -10,216 |
EBIT | -12,818 | -7,804 | -6,381 | -10,219 |
Net Income | -12,511 | -7,420 | -5,872 | -9,955 |
Net Change In Cash | 0 | 6 | 6 | 0 |
Free Cash Flow | -5,936 | -6,673 | -8,986 | -9,129 |
Cash | 9,576 | 10,635 | 11,961 | 21,144 |
Basic Shares | 46,131 | 46,082 | 36,335 | 37,862 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -9 | -36 | -54 | |
EBITDA | -32,476 | -13,896 | -21,450 | 17,886 |
EBIT | -32,485 | -13,896 | -21,486 | 17,832 |
Net Income | -31,476 | -13,862 | -21,708 | -78,544 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -28,794 | -8,185 | -16,677 | -18,423 |
Cash | 11,961 | 41,100 | 42,044 | 58,765 |
Basic Shares | 31,571 | 17,383 | 13,967 | 7,358 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.27 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.19 |
2023-09-30 | -$0.26 |
